ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,718.57
      0.28%
      US Tech 100
      19,312.80
      0.08%
      Dow Jones
      42,124.65
      0.15%
      Brent Oil
      74.00
      0.36%
      Bitcoin
      63,118.53
      -0.33%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Histogenics Corporation (HSGX) Quote

      Histogenics Corporation

      Histogenics Corporation (HSGX)

      NASDAQ
      0.162
      0.00
      (0.00%)
      Closed September 23 4:00PM
      Delayed by 15 minutes
      0.00
      0.00
      (0.00%)
      After Hours: -
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.162
      Bid
      0.164
      Ask
      0.166
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      41.553M
      Previous Close
      0.162
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      256,502,000
      Dividend Yield
      -
      PE Ratio
      -4.23
      Earnings Per Share (EPS)
      -0.25
      Revenue
      6.04M
      Net Profit
      -63.08M

      About Histogenics Corporation

      Histogenics Corp is a regenerative medicine company. It is focused on developing and commercializing products in the musculoskeletal segment of the marketplace. The company's first product candidate, NeoCart, is an tissue implant that utilizes various aspects of regenerative medicine platform to tre... Histogenics Corp is a regenerative medicine company. It is focused on developing and commercializing products in the musculoskeletal segment of the marketplace. The company's first product candidate, NeoCart, is an tissue implant that utilizes various aspects of regenerative medicine platform to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. Histogenics operates in two geographic regions: The United States (Massachusetts) and Israel (Tel Aviv). Regenerative medicine technologies encompass a variety of therapeutic approaches, including tissue engineering, cell-based therapies, gene therapy, small molecules and biologics, stem cells and biobanking. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Ortho,prosth,surg Appl,suply
      Website
      ocugen.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      2020

      Ask ADVFN Intelligence (AI)

      HSGX Latest News

      More News

      Entera Bio Establishes U.S. Headquarters and Announces Jonathan Lieber as Chief Financial Officer

      BOSTON and JERUSALEM, Nov. 21, 2019 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX) today announced that it has established a U.S. Headquarters in the Boston area and has hired Jonathan...

      November 21 2019
      GlobeNewswire Inc.

      Histogenics Corporation Announces Approval of Merger by Stockholders at Special Meeting

      BOSTON, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) (the “Company” or “Histogenics”) today announced that all proposals related to its proposed merger with Ocugen...

      September 26 2019
      GlobeNewswire Inc.

      Histogenics Corporation Announces Adjournment of its Special Meeting to Thursday, September 26, 2019

      BOSTON, Sept. 12, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) (the “Company” or “Histogenics”) today announced that it convened and then adjourned, without conducting any...

      September 12 2019
      GlobeNewswire Inc.

      Histogenics Corporation Announces Intent to Convene and Adjourn Its Special Meeting

      BOSTON, Sept. 11, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) (the “Company” or “Histogenics”) today announced that it intends to convene and then adjourn, without conducting...

      September 11 2019
      GlobeNewswire Inc.

      Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel...

      BOSTON, Mass. and MALVERN, Penn., April 08, 2019 (GLOBE NEWSWIRE) -- Histogenics Corporation (Nasdaq: HSGX) and Ocugen, Inc., a privately held clinical-stage biopharmaceutical company focused...

      April 08 2019
      GlobeNewswire Inc.

      Jonathan Lieber Joins Danforth Advisors as Managing Director

      SOMERVILLE, Mass., Feb. 12, 2019 (GLOBE NEWSWIRE) -- Danforth Advisors, LLC, a consulting firm providing operational accounting and finance support, together with CFO services, for private and...

      February 12 2019
      GlobeNewswire Inc.

      Histogenics and FDA Conclude Discussions Regarding NeoCart® Phase 3 Clinical Trial Data and Regulatory Pathway

      WALTHAM, Mass., Dec. 21, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), today provided an update on the NeoCart regulatory pathway based on discussions with the...

      December 21 2018
      GlobeNewswire Inc.

      Histogenics and FDA Continue to Discuss NeoCart® Phase 3 Clinical Trial Data and Potential Regulatory Pathway

      WALTHAM, Mass., Nov. 29, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...

      November 29 2018
      GlobeNewswire Inc.

      Histogenics Corporation Announces Third Quarter 2018 Financial and Operating Results

      WALTHAM, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- ‒ Histogenics and FDA Continue Discussions on NeoCart® Phase 3 Data and Potential BLA Submission ‒‒ October 2018 Financing Expected to...

      November 08 2018
      GlobeNewswire Inc.

      Histogenics and FDA to Continue Discussions on NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway

      WALTHAM, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Histogenics Corporation (Histogenics) (Nasdaq: HSGX), a leader in the development of restorative cell therapies that may offer rapid-onset pain...

      November 01 2018
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      KAVLKaival Brands Innovations Group Inc
      $ 1.33
      (129.71%)
      		182.46M
      LASELaser Photonics Corporation
      $ 18.8671
      (81.24%)
      		13.54M
      TGLTreasure Global Inc
      $ 1.18
      (73.45%)
      		139.95M
      NVVENuvve Holding Corporation
      $ 6.68
      (70.41%)
      		31.34M
      UXINUxin Ltd
      $ 2.42
      (52.68%)
      		18.24M
      ELABElevai Labs Inc
      $ 0.10545
      (-62.34%)
      		23.66M
      ADTXAditxt Inc
      $ 0.262
      (-31.52%)
      		3.17M
      FRGTFreight Technologies Inc
      $ 0.081
      (-28.82%)
      		26.36M
      ANEBAnebulo Pharmaceuticals Inc
      $ 2.23
      (-27.60%)
      		113.78k
      STSSSharps Technology Inc
      $ 0.1722
      (-27.06%)
      		2.27M
      XPONExpion360 Inc
      $ 0.1144
      (34.91%)
      		432.14M
      NVDANVIDIA Corporation
      $ 116.26
      (0.22%)
      		206.23M
      INTCIntel Corporation
      $ 22.56
      (3.30%)
      		184.43M
      KAVLKaival Brands Innovations Group Inc
      $ 1.33
      (129.71%)
      		182.45M
      TGLTreasure Global Inc
      $ 1.18
      (73.45%)
      		139.93M

      Discussion

      View Full Feed
      Trinityz1 Trinityz1 3 minutes ago
      An elderly couple had just learned how to send text messages on their cell phones.
      The wife was a romantic type and the husband was more of a no-nonsense guy.
      One afternoon the wife went out to meet a friend for coffee.
      She decided to send her husband a romantic text message and
      gfp927z gfp927z 4 minutes ago
      Celsius - >>> 1 Growth Stock Down 64% to Buy Right Now


      by James Brumley

      Motley Fool

      Sep 21, 2024


      https://finance.yahoo.com/news/1-growth-stock-down-64-105500499.html


      There's no getting around the fact
      CELH
      WALLnut WALLnut 4 minutes ago
      My estimate is $1.89 on the conservative side....but again who really knows? The device is that promising like no other OTC ticker...ever...so it could fly extremely high or hit my estimates. Long term after IDE and all 3 phrases competed, I could see pps well over $20 easy...unless Vivos is bough
      RDGL
      gfp927z gfp927z 4 minutes ago
      Celsius - >>> 1 Growth Stock Down 64% to Buy Right Now


      by James Brumley

      Motley Fool

      Sep 21, 2024


      https://finance.yahoo.com/news/1-growth-stock-down-64-105500499.html


      There's no getting around the fact
      CELH
      gfp927z gfp927z 5 minutes ago
      Celsius - >>> 1 Growth Stock Down 64% to Buy Right Now


      by James Brumley

      Motley Fool

      Sep 21, 2024


      https://finance.yahoo.com/news/1-growth-stock-down-64-105500499.html


      There's no getting around the fact
      CELH
      Trinityz1 Trinityz1 6 minutes ago
      that was awesome Larry
      Smilin_B Smilin_B 6 minutes ago
      He will never do a single day in jail, especially when the regulators and SEC have authorized every move he's made this far
      MULN
      LakeshoreLeo1953 LakeshoreLeo1953 7 minutes ago
      One of the most abused English phrases.
      At the very least, understanding why that is so should lend focus to the arguments you wish to articulate.
      AVXL
      Smilin_B Smilin_B 8 minutes ago
      No volume

      No interest 

      New management isn't paying attention to shareholder requests for simple information 

      CEO Lamb just very well may be a James Ballas Jr

      Sad...
      UBQU
      tiger_trader tiger_trader 8 minutes ago
      Why are you here?
      IGPK
      leavetheguntakethecannolis leavetheguntakethecannolis 10 minutes ago
      Come on Forest, you can do better than that.
      IPIX
      Wyoming Thunder Wyoming Thunder 10 minutes ago
      shrimp cooled servers?
      SHMP
      georgeofthebungle georgeofthebungle 11 minutes ago
      Yes. I was just happy to hear back from him. Maybe we won’t be kept in the dark much longer like we had been with Durham.
      AFFU
      blackhawks blackhawks 11 minutes ago
      I was going to alert you to Colbert's guest list for tonight's show.
      theswordman theswordman 11 minutes ago
      Posting--doxxing with personal information is not "insensitive remark"

      You and dolphin have lost all credibility with your nonsense today. But in your case you didn't ever really have any. But make sure and double down in case someone might still be giving you benefit of doubt--kudos
      CYDY
      goldenpath8 goldenpath8 13 minutes ago
      Doom Is the West’s Future
      visit - www.cogwriter.com - see link with wording in above title
      LWLG
      StayHumble StayHumble 14 minutes ago
      ♻️7/7/23 $HCMC🟩Entered a Vape Patent Licensing Agreement🟩 @healthiercmc $HCWC
      $HCMC grants to licensee a non-exclusive right & license to make|use|offer|sell, sell,& import licensed products in the USA. Licensee will pay based on net sales of all products
      HCMC HCWC
      JusDePomme JusDePomme 15 minutes ago
      The more u respond to bashers ...u will get same result ! Ignore them!
      AAPJ
      mikepgator mikepgator 15 minutes ago
      It might depend on how well the company markets this milestone.
      RDGL
      Acme Investments Acme Investments 15 minutes ago
      Top of the boards!! Good job fellas!! Nothing much to add!! Rates were cut so I'm looking for all markets to do well in the next few months!! Are you Prepared??
      BCAP
      Top Penny Top Penny 16 minutes ago
      I reached out, I want size
      MHRE
      StayHumble StayHumble 17 minutes ago
      idiot, did KramerNakedShort🟩4Bill+$DBMM shares4Charity?🟩


      Source: TDA 2014 Chart https://investorshub.advfn.com/uimage/uploads/2023/1/29/cpbxb2014_dbmm_trade_data.png Source: https://fintel.io/s/us/dbmm
      https://investorshub.advfn.com/uimage/uploads/2023/
      DBMM
      powerbattles powerbattles 17 minutes ago
      Sometime in 2023 feels like a long wait. I rarely invest in OTC stocks and hold onto them for so long, but this one has all the ingredients I believe could lead to significant profits. Waiting is the hardest part. If making money were easy, patience wouldn’t be necessary.
      EMGE

      Your Recent History

      NASDAQ
      HSGX
      Histogenics
      Delayed Upgrade Clock